Is it unreasonable to think that our FDA could approve using European data. They have used European data in the past. They could give orphan drug status in Glio, as the drug certainly deserves it. Why is there thoughts that the use of the Drug here in the US may not be approved. We have had approval for Vaccines that were brought out of cuba by other companies.
I'd also like to know how many insider shares were sold as I havent seen that data. Many companies, there is insider selling and buying, so whats the point? If they were dumping all their shares then I would be selling too.
So are you saying Randy that the future gains/risk reward, will be slower/ with increaserisk? We already held over a year to see almost tripling of initial investment. I sold 1/3 a few days ago holding rest for future rewards I hope.